Ask about their training, certifications, lineage or mentorship, years of experience, emergency protocols, contraindication screening, dosing philosophy, and whether they have experience working with patients who have your health conditions
10.1021/acsnano.6b03013 271 SarricaA.KirikaN.RomeoM.SalmonaM.DiomedeL
The absence of human data means researchers using KLOW must establish their own safety protocols, justify dosing extrapolations from animal models, and navigate heightened institutional review scrutiny
After decades in an industry, seeing so many men wronged by invasive, flawed treatments, I'm proud to recommend this
Flunixin meglumine is a broad-spectrum inhibitor specifically targeting both cyclooxygenase- 1 (COX- 1) and COX- 2